BIO KOREA 2009

Speakers

HOME > Conference > Speakers

Plenary Session

Dr. Tim Hunt
(Sir Richard Timothy Hunt)
Principal Scientist
Cancer Research UK Clare Hall Laboratories		 G. Steven Burrill
CEO
Burrill & Company		 Jeong-Sun SEO
Prof.,
College of Medicine,
Seoul Nat'l Univ.
for more for more for more

Conference

Track 1. BioIndustry in UK & Korea

Session 1. Microfluidics System
Andrew J. deMELLO
Co-founder,
Molecular Vision Ltd.
Prof., Chemistry,
Imperial College London 		Jaebum CHOO
Prof.,
Dept. of Applied Chemistry,
Hanyang Univ.		 Jon M. COOPER
Co-founder, MODE DX Ltd. Leader, Bioengineering,
Univ. of Glasgow
for more for more for more
Session 2. High Throughput Analysis for Diagnosis and Drug Discovery
Robin J. LEATHERBARROW
Prof., Chemistry,
Imperial College London 		MoonHee HAN
CEO, Proteotgen, Inc.		 Danny O'HARE
Co-founder, Medermica Ltd. Leader, Bioengineering,
Imperial College London
for more for more for more
Session 3. Stem Cell and Biologics
Yeup YOON
Director,
Mogam Biotechnology
Research Inst. 		Hyung-Min CHUNG
President,
CHABio&Diostech Co., Ltd.		 Athanasios MANTALARIS
Co-founder, MedCell Ltd. Leader, Chemical Engineering, Imperial College London
for more for more for more
Session 3. Stem Cell and Biologics
Nigel Whittle
R&D Specialist, UKTI R&D Programme, UK Trade & Investment
 Naomitsu ABE
Senior Manager, Primary Markets, London Stock Exchange - Hong Kong		 Fabian SEYMOUR
Innovation Manager, Cels Group
주요이력보기 주요이력보기 주요이력보기
Sangdeok HAN
Director & Chief Secretary,
Chairman’s Secretary Office,
Sewon Cellontech Co., Ltd.
주요이력보기

Track 2. Issues to Address in Life Science BD & Funding

Session 1. Update on Changing Trends in Venture Investments
Mike MURRAY
Managing Director,
Sosei R&D Ltd. 		Hui-Hsing MA
General Partner, Life Sciences, TVM Capital		 Jeong Hyun KIM
Executive Director, E&Networks Venture Investment
for more for more for more
Session 2. Critical Issues for Successful IR of Life Science Venture Companies
Nelson TENG
Managing Partner,
Charter Life Sciences		 Adam BRISTOL
Portfolio Manager, Biotechnology Value Fund, LP		 Stephen LEE
Principal,
Bio-Strategies Consulting
for more for more for more

Track 3. Technology Transfer and Licensing
:Technology Innovation and Commercialization for Life Science

Session 1. Building and Enforcing IP Value in Korea
Sunhee (Sunny) LEE
Partner,
Sughrue Mion, PLLC.		 Kyujeong AHN
Patent Examiner,
Biotechnology Examination Div.,
Industrial Property Office		 Richard CHIN
CEO, Inst. for OneWorld Health
for more for more for more
Session 2. The Journey from Discovery to the Market in the Life Sciences
Steven M. FERGUSON
Deputy Director,
Licensing & Entrepreneurship,
Office of Tech. Transfer,
Nat'l Institutes of Health (U.S.)		 Ann M. HAMMERSLA
Chief, Office of Tech. Transfer, Nat'l Institutes of Health (U.S.)		 Sung-Joo E. LEE
Deputy General Manager, R&D Strategic Planning, LG Life Sciences, Ltd.
for more for more for more
Session 3. Supporting Activities for Technology Commercialization
Ann M. HAMMERSLA
Chief, Office of Tech. Transfer, Nat'l Institutes of Health (U.S.)		 Steven M. FERGUSON
Deputy Director,
Licensing & Entrepreneurship,
Office of Tech. Transfer,
Nat'l Institutes of Health (U.S.)		 Dianne GLENN
DI, Corelli Consulting
for more for more for more
   
Benjamin P. CHEN
Managing Director,
Burrill & Company
for more    
Session 4. View of Negotiation for Investment & Cooperation
Nancy T. CHANG
Chairman & Sr. Managing Director, Asia, OrbiMed Advisors 		Stephen M. SAMMUT
Venture Partner, Burrill & Company / Senior Fellow, Wharton School 		Benjamin P. CHEN
Managing Director,
Burrill & Company
주요이력보기 주요이력보기 주요이력보기

Track 4. Traditional Medicine : R&D on Traditional Medicine

Session 1. Recent Trends of R&D for Traditional Medicine in East-Asia
Hong Xin CAO
President,
China Academy of Chinese Medical Sci.		 Toshihiko HANAWA
President,
Kitasato Univ. Oriental Medicine Research Center		 Yun-Lian LIN Research Fellow
& Deputy Director, Medicinal Chemistry, Nat'l Research Inst. of Chinese Medicine
for more for more for more
   
Ki-ok KIM
President,
Korea Inst. of Oriental Medicine		    
for more    
Session 2. Recent Policy Trends of Traditional Medicine in East-Asia
Zhiren XU
Director-general,
Dept. of Medical Affairs Management,
State Administration of Traditional Chinese Medicine 		I-hsin LIN
Chairperson,
Dept. of Health,
Executive Yuan,
Committee on Chinese Medicine and Pharmacy		 Yong-ho KIM
Director, Bureau of TKM,
Ministry for Health, Welfare
and Family Affairs
for more for more for more

Track 5. Korea-Scotland Joint Symposium

Welcome Speech
   
Tony BAKER
Director,
Life Sciences, Scottish Development Int'l 		   
for more    
Session 1. Diabetes and Pharmacogenomics
Calum SUTHERLAND
Prof.,
Dundee Diabetes Research Center, Ninewells Medical School of Dundee 		Jae-Gook SHIN
Prof.,
Dept. of Pharmacology and Clinical Pharmacology, Pharmacogenomics Research Center, College of Medicine, Inje Univ. 		Colin NA PALMER
Chair of Pharmacogenomics, Biomedical Research Inst., Univ. of Dundee
for more for more for more
Session 2. Diabetes and Therapeutics
Stephen M. HAMMOND
Prof.,
Yoshitomi Inst. in Neurosciences, Univ. of Glasgow 		Thomas Jung-Woog SHIN
Prof.,
Dept. of Biomedical Engineering, Inje Univ. 		Steve GIBSON
Director, Vitrology Ltd.
for more for more for more

Track 6. Recent Advances of Stem Cell Differentiation

Session 1. Cell Differentiation from Human ES Cells
Hyung-Min CHUNG
President,
CHABio&Diostech Co., Ltd.		 Jong-Hoon KIM
Associate Prof.,
Lab. of Stem Cell Biology,
College of Life Sciences & Biotechnology,
Korea Univ.		 Shi-Jiang LU
Senior Director,
Stem Cell & Regenerative Medicine Int'l
for more for more for more
Session 2. Derivation of Tissue Specific Stem Cell
Jeong Mook LIM
Prof.,
Dept. of Agricultural Biotech.,
Seoul Nat'l Univ 		Kinarm KO
Research Associate, Dept. of Cell and Developmental Biology, Max Planck Inst. for Molecular Biomedicine 		Dong Wook HAN
Post Doc., Dept. of Cell and Developmental Biology, Max Planck Inst. for Molecular Biomedicine
for more for more for more

Track 7. APEC Harmonization Center Workshop

Session 1. To be announced
 
 
  		 
 		  
 
 
for more for more for more
Session 2. To be announced
 
 
  		 
 		  
 
 
for more for more for more
Session 3. To be announced
 
 
  		 
 		  
 
 
for more for more for more

Track 8. Regenerative Medicine

Session 1. Recent Advances of Stem Cell
Yong-Mahn HAN
Prof.,
Dept. of Biological Sciences,
KAIST		 Youngsook SON
Prof., College of Life Sci.,
Kyung Hee Univ.		 Dong-Wook KIM
Prof.,
Stem Cell Research Center,
Yonsei Univ.
for more for more for more
Session 2. Global Development Trends for Cell Therapy
Wonil OH
Director,
Biomedical Research Inst.,
MEDIPOST, Co., Ltd.
 Yukio HASEGAWA
President & CEO,
CellSeed Co.		 Mihyung KIM
Managing Director,
Anterogen Co. Ltd.
for more for more for more
Session 3. Recent Advances of Tissue Engineering
Rui REIS
Prof., 3B' Research Inst.,
Univ. of Minho
 Byung Hyun MIN
Prof., Orthpeadic Surg.,
Ajou Univ. Medical School		 Minoru UEDA
Prof., Dept. of Oral and Maxillofacial Surgery,
School of Medicine,
Nagoya Univ.
for more for more for more

Track 9. Pharmaceutical Strategy for Incrementally Modified Drug

Session 1. Efficient Drug Delivery for IMD Strategies
Hoo-Kyun CHOI
Prof., College of Pharmacy , Chosun Univ.		 Soo-Jeong LIM
Associate Prof.,
Dept. of Bioscience & Bioengineering,
Sejong Univ.		 Sung-Joo HWANG
Prof., College of Pharmacy, Chungnam Nat'l Univ.
for more for more for more
Session 2. IMD Strategies for Biopharmaceuticals
Tae Gwan PARK
Prof.,
Dept. of Biological Sciences,
KAIST		 Yong-Hee KIM
Associate Prof.,
Dept. of Bioengineering,
Hanyang Univ.		 Moon Suk KIM
Assistant Prof.,
Dept. of Molecular Sci. and Tech.,
Ajou Univ.
for more for more for more
Session 3. Advanced IMD Technologies for Next Generations
Jonghwi LEE
Associate Prof.,
Dept. of Chemical Engineering and Materials Sci.,
Chung-Ang Univ.		 Myung-Ok PARK
CEO, BiopolyMed Inc.		 Seongbong JO
Assistant Prof.,
Pharmacy/Pharmaceutics,
The Univ. of Mississippi
for more for more for more

Track 10. Strategy for Overseas Generic Marketing

Session 1. Innovative and Specific Strategy for the Participation of Korean Generic
Industry for the World-market
Ram MURTY
President & CEO,
Murty Pharmaceuticals, Inc. 		Beom-Jin LEE
Prof., College of Pharmacy , KangWon Nat'l Univ.		 Gwan Sun LEE
Managing Research Director & Head of Hanmi Research Center, Hanmi Pharm. Co., Ltd.
for more for more for more
Session 2. Market Analysis and Measures for Korean Generic Drug Export to the World
Market
Soo Youn CHUNG
Chief, Bioequivalence Div., Korea Food & Drug Administration		 Chung Keel LEE
Special Advisor to the Commissioner,
Korea Food & Drug Administration		 Sang-Joon LEE
Executive Vice President,
Business Div.,
Kolon Life Science, Inc.
for more for more for more
Session 3. Generic Drug Patent Strategy for International Marketing
Joo Mee KIM
Partner,
Rothwell, Figg, Ernst &
Manbeck, P.C.		 Kyung Ae YOON
Director,
Korea Inst. of Patent Information		 So Young AHN
Patent Attorney, Dr. Ahn Int'l Patent Law Office
주요이력보기 for more for more
Eun-Ju RYU
Director, Emerging Market Business Unit, Pfizer Inc.
New York
for more

Track 11. Therapeutic Antibody

Session 1. Therapeutic Antibody 1
Zhenping ZHU
Vice President & Global Head, Protein Sciences & Design, Novartis Biologics		 Shin-Jae CHANG
Vice President, Celltrion, Inc.		 Kum-Joo SHIN
Director, Research, Abxign
for more for more for more
Session 2. Therapeutic Antibody 2
Herren WU
Vice President & Global Head of Tech. and Lead Generation, Antibody Discovery & Protein Engineering, MedImmune		 Kyoung E. KIM
General Manager, KIM, General Manager, BIO Businee Team, Hanwha Group/Dream Pharma		 June-Young PARK
Director,
Business Development,
Isu Abxis Co., Ltd.
for more for more for more
Session 3. Therapeutic Antibody 3
Henrik IHRE
Program Manager Antibodies, Life Sciences Div., GE Healthcare		 Peter PARK
Senior Director, Discovery Research, ImmunoGen, Inc.		 Se-Ho KIM
Research Director,
Green Cross Corp.
for more for more for more
Dae Hee KIM
Principal Investigator,
Scripps Korea
for more

Track 12. u-Health

Session 1. Policies and Vision
Young Hae KIM
Director,
u-Project Team / u-Service Div.,
Nat'l Information Society Agency		 Duk Won KIM
Team Manager, Marketing Team, Evercare		 Kenich SASAKI
Senior Consultant,
Nomura Research Inst.
for more for more for more
Session 2. Technology and Standardization
Suk Wha KIM
Prof.,
Dept. of Plastic Surgery,
College of Medicine,
Seoul Nat'l Univ. 		Woo Kyeong SEONG
Director,
Medical IT Comvergence Research Center,
Korea Electronics Tech.		 Kyung Soo JIN
Prof.,
Dept. of Medical Electronics,
Chungbuk Provincial College
for more for more for more
Session 3. Business Models
Kun-Ho YOON
Prof.,
Dept. of Endocrinology & Metabolism,
The Catholic Univ. of Korea		 Young Woo PAE
Manager,
IBM Ubiquitous Computing Lab,
IBM Korea		 Tae Il KWON
Director,
Healthcare Business Div.,
Uracle
for more for more for more

Track 13. Recent Trends on Biochip Technology

Session 1. Recent Progress in Protein and DNA Chips
Shao Q YAO
Associate Prof.,
Dept. of Chemistry,
Nat'l Univ. of Singapore 		Hak-Sung KIM
Prof.,
Dept. of Biological Sciences,
KAIST		 Suk Woo NAM,
Associate Prof.,
Dept. of Pathology,
College of Medicine,
The Catholic Univ.
for more for more for more
Session 2. Nano and Biomedical Sensor Technologies
Hagen THIELECKE
Head,
Dept. of Biohybrid Systems,
Fraunhofer IBMT 		Jae-Chul PYUN
Assistant Prof.,
Dept. of Materials Sci. and Engineering,
Yonsei Univ.		 Sangmin JEON
Associate Prof.,
Dept. of Chemical Engineering,
Pohang Univ. of Sci. and Tech.
for more for more for more
Session 3. Microfluidic Chips for Cells
Ali KHADEMHOSSEINI
Prof., Harvard-MIT HST,
Harvard Medical School		 Noo Li JEON
Associate Prof.,
School of Mechanical and Aerospace Engineering,
Seoul Nat'l Univ.		 Je-Kyun PARK
Prof.,
Dept. of Bio and Brain Engineering,
KAIST
for more for more for more

Track 14. Clinical Drug Development

Session 1. Early Phase Product Development:
Helping Korean Companies to Access Western Markets
Maree SMITH
CEO, TetraQ 		Suzanne ELLIOTT
Operations Manager,
Q-Pharm Pty Ltd.		 Dianne Jackson-Matthews
Deputy Group Director,
ERA Consulting
for more for more for more
Session 2. New Tools for Early Phase Clinical Drug Development
Kyung-Sang YU
Prof.,
College of Medicine and Hospital,
Seoul Nat'l Univ.		 Kyungsoo PARK
Associate Prof.,
Pharmacology, College of Medicine,
Yonsei Univ.		 Hyeong-Seok LIM
Assistant Prof.,
Dept. of Clinical Pharmacology and Therapeutics,
Asan Medical Center,
Univ. of Ulsan
for more for more for more
Session 3. Strategies for Successful Development of Biopharmaceuticals
Seok H. LEE
Senior Advisor, Celltrion, Inc.		 Woo Suk KOH
Senior Researcher,
Korea Inst. of Toxicology, KRICT		 Chulho PARK
Head, Process Sciences,
Pre-Clinical Development,
aTyr Pharma
for more for more for more

Track 15. Bioactive Medical Implants

Session 1. Biocompatible Implants in Medicine
Dave GRAINGER
Prof. & Chair,
Dept. of Pharmaceutics,
Univ. of Utah		 Hun Kuk PARK
Prof.,
Dept. of Biomedical Engineering,
School of Medicine,
Kyung Hee Univ.		 Ki Dong PARK
Prof.,
Dept. of Molecular Sci.
and Tech.,
Ajou Univ.
for more for more for more
Session 2. Cardiovascular Implants
Dehua CHANG
Assistant Prof.,
Inst. of Advanced Biomedical Engineering and Sci.,
Tokyo Women's Mediclal Univ. 		Dong Hoon CHOI
Prof.,
Dept. of Cardic Internal Medicine,
School of Medicine,
Yonsei Univ.		 Yang Ha CHO
Director,
Medical Device Standardization,
Medical Device Evaluation,
Korea Food & Drug Administration
for more for more for more
Session 3. Skeletal (Spinal, Orthopedic, and Dental) Implants
Young KU
Prof.,
Dept. of Periodontology,
School of Dentistry,
Seoul Nat'l Univ.		 Yong Sik KIM
Prof., Dept. of Neurological Surgery, ASAN Medical Center, College of Medicine, Univ. of Ulsan		 Sung Jae LEE
Prof.,
Dept. of Biomedical
Engineering,
Inje Univ.
for more for more for more

Track 16. Regulatory and GMP Compliance

Session 1. Updated Regulatory Issues for Biologicals
Chung Keel LEE
Special Advisor to the Commissioner,
Korea Food & Drug Administration		 Younjoo PARK
Director, Biologics Research Div., Nat’l Inst. of Food & Drug Safety Evaluation, Korea Food
& Drug Administration		 Seunghwa HONG
Director,
Nat'l Inst. for Food & Drug
Safety Evaluation
for more for more for more
Session 2. GMP Facility Design and Operation
Luke DeMAYO
Senior Technical Manager, Process Tech., Middough Inc. 		Thomas PAUST
Director,
Satorius Stedim Biotech		 Yeong Ok BAIK
Director,
Dept. of Biologics Manufacturing,
KBCC, KITECH
for more for more for more
Session 3. QC/QA
K.C. CHENG
Director,
Analytical and Formulation Development,
Medarex, Inc. 		Do Yeon LEE
Manager, QA Team 1,
Center for Quality Assurance,
Pharmaceutical BU.,
CJCheilJdang Corp.		 MinYoung SOH
Senior Vice President,
Celltrion, Inc.
for more for more for more

Track 17. Vaccine

Session 1. Vaccine Industry in Asia: Challenge and Opportunity
John CLEMENS
Secretary General,
Int'l Vaccine Inst.		 Giang GAO
CTO, Sinovac		 Thu Van NGUYEN
Director General, Vaccine,
The Company for Vaccine and Biological No.1
for more for more for more
   
Byung Geon RHEE
Executive Vice President, Green Cross Corp.		    
for more    
Session 2. Prospective Vaccine R&D
Dennis J. KOPECKO
Lab Chief, Div. of Bacterial, Parasitic and Allergenic Products, FDA-CBER		 Baik Lin SEONG
Prof., Yonsei Univ.		 Youngchul SUNG
Prof., Dept. of Life Sci., Pohang Univ. of Sci. and Tech.
for more for more for more
   
Joon Haeng RHEE
Prof., Dept. of Microbiology,
Medical School,
Chonnam Nat'l Univ.		    
for more    

Track 18. Next-generation Sequencing
: Next-generation Sequencing Towards Personalized Medicine

Session 1. Application of Next-generation Sequencing to Personal Genomics
Charles LEE
Prof., Harvard Cancer Center, Harvard Univ.		 Ituro INOUE
Prof., School of Medicine,
Tokai Univ.		 Sun KIM
Prof., School of Informatics, Indiana Univ.
for more for more for more
Session 2. The Present of Next-generation Genome Sequencing in Korea
Yoon Shin CHO
Principal Research Scientist, Center for Genome Sci.,
Korean Nat'l Inst. of Health, KCDC		 Kap-Seok YANG
CTO, Macrogen Inc.		 Yong Sung KIM
Principle Investigator, Medical Genomic Research Center, Korean Research Inst. of Biosci. and Biotech.
for more for more for more
Session 3. Introduction of Next-generation Sequencing Technology to Personal Medicine
Yafei LIU
Head,
Sequencing Business,
Illumina		 Chinnappa KODIRA
Director, Genomics,
454 Life Sciences Corp.		 Mike PAYNE
Regional Lead Applications Support, Applied Biosystems
for more for more for more

Track 19. Botanical New Drug Discovery and Development

Session 1. Development of Botanical New Drug
Hocheol KIM
Prof., Dept. of Herbal Pharmacology, College of Oriental Medicine, Kyung Hee Univ. / CEO, NeuMed Inc.		 Bongyong LEE
R&D General Manager, Life Sci. R&D Center, SK Chemicals		 Hyeong-Kyu LEE
Vice President & General Director,
Bio-therapeutics Research Inst.,
Korea Research Inst. of Bioscience and Biotechnology
for more for more for more
Session 2. Regulation of Botanical Products
Sang Hyun SUNG
Assistant Prof.,
College of Pharmacy,
Seoul Nat'l Univ. /
CEO, Elcom Science Co., Ltd.		 Shin Jung KANG
Director,
Medicinal Herbal Products Div.,
Korea Food & Drug Administration		 Hye Young LEE
Senior Officer, Div. of Functional Food, Dept. of Nutrition & Functional Food, Korea Food & Drug Administration
for more for more for more
Session 3. Global Market of Botanical Products
Hee Min RHEE
Principal Investigator,
Int'l Scientific Standard, Inc.		 Ming-Wei WANG
Director,
The Nat'l Center for Drug Screening		 Hirobumi OHAMA
Chairman of the Board,
The Japanese Inst. for Health Food Standards
for more for more for more
Top